Invivyd, Inc. (IVVD) Financials

IVVD Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 218.9 million 37.8 million
March 31, 2026 241.7 million 38.7 million
Dec. 31, 2025 276.9 million 35.3 million
Sept. 30, 2025 139.2 million 46.1 million

IVVD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -43.5 million 2.9 million
March 31, 2026 -42.4 million 2.7 million
Dec. 31, 2025 -15.5 million 2.6 million
Sept. 30, 2025 -8.3 million 3.1 million

IVVD Net Income

No data available :(

IVVD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 160.1 million 6.8 million -
March 31, 2026 184.2 million - 8.6 million
Dec. 31, 2025 226.7 million - 2.5 million
Sept. 30, 2025 85.0 million - 2.7 million

IVVD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 320.4 million
March 31, 2026 309.7 million
Dec. 31, 2025 172.2 million
Sept. 30, 2025 170.2 million

IVVD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 510000 29.4 million 29.5 million -
March 31, 2026 726000 30.7 million 24.6 million -
Dec. 31, 2025 - 10.0 million 18.6 million -
Sept. 30, 2025 - 8.0 million 15.0 million -

IVVD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 14.3 million 1.3 million
March 31, 2026 13.7 million 1.5 million
Dec. 31, 2025 17.2 million 1.1 million
Sept. 30, 2025 13.1 million 1.1 million

IVVD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IVVD

Price: $1

52 week price:
0.48
3.07

Earnings Per Share: -0.31 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 203.9 million

Links: